MedTrace Logo

Genetic and Epigenetic Basis of Chronic Wounds

NCT03793062 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 256

Last updated 2026-04-14

No results posted yet for this study

Summary

This pilot study is designed for chronic wounds that fail to heal in a timely manner carry specific genetic signatures. These genetic signatures will be studied using debrided wound tissue that is removed by the wound care provider as part of standard of care. The reference genomic signature will be evaluated by obtaining blood samples and will be compared with wound debrided tissue genomic signature to understand wound specific genomic changes.

Conditions

  • Chronic Wounds

Interventions

OTHER

No Interventions

Not applicable - No Interventions

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Chandan K Sen, PhD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-04
Primary Completion
2028-06-01
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793062 on ClinicalTrials.gov